638 related articles for article (PubMed ID: 17702652)
1. Rational design of vaccines against tuberculosis directed by basic immunology.
Reece ST; Kaufmann SH
Int J Med Microbiol; 2008 Jan; 298(1-2):143-50. PubMed ID: 17702652
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.
Sable SB; Kalra M; Verma I; Khuller GK
Clin Immunol; 2007 Mar; 122(3):239-51. PubMed ID: 17208519
[TBL] [Abstract][Full Text] [Related]
3. [Advance in DNA vaccine against Mycobacterium tuberculosis].
Wang BL; Wang HH
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Nov; 27(11):787-90. PubMed ID: 15634398
[No Abstract] [Full Text] [Related]
4. Advances in tuberculosis vaccine strategies.
Skeiky YA; Sadoff JC
Nat Rev Microbiol; 2006 Jun; 4(6):469-76. PubMed ID: 16710326
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis vaccine research: the impact of immunology.
Barker LF; Brennan MJ; Rosenstein PK; Sadoff JC
Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells.
Lindenstrøm T; Agger EM; Korsholm KS; Darrah PA; Aagaard C; Seder RA; Rosenkrands I; Andersen P
J Immunol; 2009 Jun; 182(12):8047-55. PubMed ID: 19494330
[TBL] [Abstract][Full Text] [Related]
7. Rational design of novel antibacterial vaccines with an emphasis on tuberculosis.
Kaufmann SH
Scand J Infect Dis; 2008; 40(8):595-600. PubMed ID: 18979596
[TBL] [Abstract][Full Text] [Related]
8. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens.
Sable SB; Plikaytis BB; Shinnick TM
Vaccine; 2007 Feb; 25(9):1553-66. PubMed ID: 17166640
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
Dietrich J; Doherty TM
APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867
[TBL] [Abstract][Full Text] [Related]
11. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
[TBL] [Abstract][Full Text] [Related]
12. Development of vaccines against tuberculosis.
Tyagi AK; Nangpal P; Satchidanandam V
Tuberculosis (Edinb); 2011 Sep; 91(5):469-78. PubMed ID: 21334259
[TBL] [Abstract][Full Text] [Related]
13. MPT-51/CpG DNA vaccine protects mice against Mycobacterium tuberculosis.
Silva BD; da Silva EB; do Nascimento IP; Dos Reis MC; Kipnis A; Junqueira-Kipnis AP
Vaccine; 2009 Jul; 27(33):4402-7. PubMed ID: 19500525
[TBL] [Abstract][Full Text] [Related]
14. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
Gao H; Li K; Yu S; Xiong S
Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
[TBL] [Abstract][Full Text] [Related]
15. Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein.
Stukova MA; Sereinig S; Zabolotnyh NV; Ferko B; Kittel C; Romanova J; Vinogradova TI; Katinger H; Kiselev OI; Egorov A
Tuberculosis (Edinb); 2006; 86(3-4):236-46. PubMed ID: 16677861
[TBL] [Abstract][Full Text] [Related]
16. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant.
Chaitra MG; Nayak R; Shaila MS
Vaccine; 2007 Oct; 25(41):7168-76. PubMed ID: 17709160
[TBL] [Abstract][Full Text] [Related]
17. [T cell-mediated immune responses and the recognition of tuberculosis antigens].
Tsujimura K; Koide Y
Kekkaku; 2010 Jun; 85(6):509-14. PubMed ID: 20662246
[TBL] [Abstract][Full Text] [Related]
18. Future vaccination strategies against tuberculosis: thinking outside the box.
Kaufmann SH
Immunity; 2010 Oct; 33(4):567-77. PubMed ID: 21029966
[TBL] [Abstract][Full Text] [Related]
19. Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications in diagnosis, and vaccine design.
Karbalaei Zadeh Babaki M; Soleimanpour S; Rezaee SA
Microb Pathog; 2017 Nov; 112():20-29. PubMed ID: 28942172
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c).
Romano M; Rindi L; Korf H; Bonanni D; Adnet PY; Jurion F; Garzelli C; Huygen K
Vaccine; 2008 Nov; 26(48):6053-63. PubMed ID: 18822333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
